Literature DB >> 17447188

Late postpartum eclampsia: report of two cases managed by uterine curettage and review of the literature.

Koji Matsuo1, Shoreh Kooshesh, Mert Dinc, Chen-Chih J Sun, Tadashi Kimura, Ahmet A Baschat.   

Abstract

The purpose of this study was describe two patients with rapid recovery of refractory late postpartum eclampsia (LPPE) following uterine curettage, and to evaluate the literature about supportive evidence for such a management in LPPE. A detailed literature search was performed focusing on studies reporting the clinical presentation, laboratory workup, imaging, and management of LPPE. Mean reported onset of LPPE was on postpartum day 7.0 +/- 2.9. Only 35.3% had a history of preeclampsia: these had earlier onset of seizures compared with the subjects without history of preeclampsia (4.3 +/- 1.4 versus 7.6 +/- 2.9 days; p < 0.005). Onset of seizure was correlated with systolic blood pressure (Pearson's r = 0.34; p < 0.05). Major associated symptoms were headaches (71.4%), visual changes (46.0%), and nausea/vomiting (22.2%); 67.5% of patients were proteinuric. The remaining laboratory tests were usually normal. Among the patients with a normal head computed tomography, magnetic resonance imaging identified additional abnormalities in 53.8% (seven of 13). A total of 69.7% of patients developed multiple seizure episodes, some of these occurred while the patient was receiving magnesium sulfate treatment; 82.5% of patients underwent magnesium therapy and approximately half of those patients required multiple antiseizure drugs. The number of seizures was only correlated with the diastolic blood pressure (Pearson's r = 0.52; p < 0.01). Even remote from delivery, headaches, visual change, and nausea/vomiting are important symptoms of LPPE. Hypertension and/or proteinuria are important diagnostic findings. LPPE is often characterized by refractory seizures and controlling the diastolic blood pressure is important. Patients presented in our case report showed no seizures after uterine curettage. This potential useful management for LPPE requires additional investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17447188     DOI: 10.1055/s-2007-976548

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  12 in total

Review 1.  Cellular and molecular mechanisms of sulfur mustard toxicity on spermatozoa and male fertility.

Authors:  Asghar Beigi Harchegani; Mahdiyeh Mirnam Niha; Milad Sohrabiyan; Mahdi Ghatrehsamani; Eisa Tahmasbpour; Alireza Shahriary
Journal:  Toxicol Res (Camb)       Date:  2018-07-09       Impact factor: 3.524

Review 2.  Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy.

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  World J Nephrol       Date:  2014-11-06

Review 3.  Angiogenic factors and preeclampsia.

Authors:  Sharon E Maynard; S Ananth Karumanchi
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

Review 4.  Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.

Authors:  Camille E Powe; Richard J Levine; S Ananth Karumanchi
Journal:  Circulation       Date:  2011-06-21       Impact factor: 29.690

5.  Aggregated transthyretin is specifically packaged into placental nano-vesicles in preeclampsia.

Authors:  Mancy Tong; Shi-Bin Cheng; Qi Chen; Joana DeSousa; Peter R Stone; Joanna L James; Lawrence W Chamley; Surendra Sharma
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

6.  Abnormal apoptosis of trophoblastic cells is related to the up-regulation of CYP11A gene in placenta of preeclampsia patients.

Authors:  Guolin He; Wenming Xu; Yan Chen; Xinghui Liu; Mingrong Xi
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

7.  Establishment of ApoE-knockout mouse model of preeclampsia and relevant mechanisms.

Authors:  Wenjuan Sun; Baoxia Cui; Fanzhen Hong; Yongping Xu
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

Review 8.  Comparison of Normal and Pre-Eclamptic Placental Gene Expression: A Systematic Review with Meta-Analysis.

Authors:  O Brew; M H F Sullivan; A Woodman
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

9.  Maspin impairs the function of endothelial cells: an implying pathway of preeclampsia.

Authors:  Ying Zhang; Hao Liu; Xinwei Shi; Fuyuan Qiao; Wanjiang Zeng; Ling Feng; Dongrui Deng; Haiyi Liu; Yuanyuan Wu
Journal:  BMC Pregnancy Childbirth       Date:  2017-09-29       Impact factor: 3.007

10.  ROS/p53/miR‑335‑5p/Sp1 axis modulates the migration and epithelial to mesenchymal transition of JEG‑3 cells.

Authors:  Wei Lu; Yu-Yan Ma; Qian-Qian Shao; Jie Liang; Tong-Tong Qi; Yi Huang; Qing-Jie Wang
Journal:  Mol Med Rep       Date:  2019-12-20       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.